
- <Centre d'Information et de documentation du CRA Rhône-Alpes
- CRA
- Informations pratiques
-
Adresse
Centre d'information et de documentation
Horaires
du CRA Rhône-Alpes
Centre Hospitalier le Vinatier
bât 211
95, Bd Pinel
69678 Bron CedexLundi au Vendredi
Contact
9h00-12h00 13h30-16h00Tél: +33(0)4 37 91 54 65
Mail
Fax: +33(0)4 37 91 54 37
-
Adresse
Détail de l'auteur
Auteur M. ROSENZWAJG |
Documents disponibles écrits par cet auteur (2)



Fever during pregnancy as a risk factor for neurodevelopmental disorders: results from a systematic review and meta-analysis / S. ANTOUN in Molecular Autism, 12 (2021)
![]()
[article]
Titre : Fever during pregnancy as a risk factor for neurodevelopmental disorders: results from a systematic review and meta-analysis Type de document : Texte imprimé et/ou numérique Auteurs : S. ANTOUN, Auteur ; P. ELLUL, Auteur ; H. PEYRE, Auteur ; M. ROSENZWAJG, Auteur ; P. GRESSENS, Auteur ; D. KLATZMANN, Auteur ; R. DELORME, Auteur Article en page(s) : 60 p. Langues : Anglais (eng) Mots-clés : Autism Children Immunology Maternal immune activation Index. décimale : PER Périodiques Résumé : BACKGROUND: Fever during pregnancy is a relatively common and most often trivial event. However, under specific conditions, it could affect significantly fetal brain development. Few studies, with inconsistent results, investigated whether fever, regardless the pathogen, could represent a risk factor for neurodevelopmental disorders (NDD) in the offspring. We aimed to explore further this question by performing a systematic review and meta-analysis. METHODS: Peer-reviewed studies exploring the occurrence of NDD in offspring after a fetal exposure to maternal fever were included. We specifically considered the impact of fever severity and duration, taking into consideration some confounding variables such as the use of antipyretic during pregnancy, the trimester in which the fever arose, the maternal age or smoking at time of gestation. MEDLINE, EMBASE, PsycINFO, Cochrane and Web of Science were searched without language restriction. PRISMA recommendations were followed. Odds ratio (OR) were pooled using random-effects meta-analysis. Heterogeneity in effect size across studies was studied using random-effects meta-regression analysis. (PROSPERO CRD42020182801). RESULTS: We finally considered ten studies gathering a total of 10,304 children with NDD. Among them, 1394 were exposed to fever during pregnancy. The selected studies were divided into 5 case-control studies and 5 cohort studies. Maternal exposure to fever during pregnancy increased the risk of NDD in offspring with an OR of 1.24 [95% CI: 1.12-1.38]. Secondary analysis revealed an increased risk for NDD when fever occurred during the first trimester of gestation [OR 1.13-95% CI: 1.02-1.26]. LIMITATIONS: We excluded studies that considered infections with no evidence of fever. Another potential limitation may be the possible heterogeneity between study designs (cohorts and case-control). CONCLUSION: Additional evidence supported the association between fever during pregnancy and increased risk for NDD in offspring. Careful monitoring should be considered for children born from mothers with a febrile episode during pregnancy (specifically during the first trimester). En ligne : http://dx.doi.org/10.1186/s13229-021-00464-4 Permalink : https://www.cra-rhone-alpes.org/cid/opac_css/index.php?lvl=notice_display&id=459
in Molecular Autism > 12 (2021) . - 60 p.[article] Fever during pregnancy as a risk factor for neurodevelopmental disorders: results from a systematic review and meta-analysis [Texte imprimé et/ou numérique] / S. ANTOUN, Auteur ; P. ELLUL, Auteur ; H. PEYRE, Auteur ; M. ROSENZWAJG, Auteur ; P. GRESSENS, Auteur ; D. KLATZMANN, Auteur ; R. DELORME, Auteur . - 60 p.
Langues : Anglais (eng)
in Molecular Autism > 12 (2021) . - 60 p.
Mots-clés : Autism Children Immunology Maternal immune activation Index. décimale : PER Périodiques Résumé : BACKGROUND: Fever during pregnancy is a relatively common and most often trivial event. However, under specific conditions, it could affect significantly fetal brain development. Few studies, with inconsistent results, investigated whether fever, regardless the pathogen, could represent a risk factor for neurodevelopmental disorders (NDD) in the offspring. We aimed to explore further this question by performing a systematic review and meta-analysis. METHODS: Peer-reviewed studies exploring the occurrence of NDD in offspring after a fetal exposure to maternal fever were included. We specifically considered the impact of fever severity and duration, taking into consideration some confounding variables such as the use of antipyretic during pregnancy, the trimester in which the fever arose, the maternal age or smoking at time of gestation. MEDLINE, EMBASE, PsycINFO, Cochrane and Web of Science were searched without language restriction. PRISMA recommendations were followed. Odds ratio (OR) were pooled using random-effects meta-analysis. Heterogeneity in effect size across studies was studied using random-effects meta-regression analysis. (PROSPERO CRD42020182801). RESULTS: We finally considered ten studies gathering a total of 10,304 children with NDD. Among them, 1394 were exposed to fever during pregnancy. The selected studies were divided into 5 case-control studies and 5 cohort studies. Maternal exposure to fever during pregnancy increased the risk of NDD in offspring with an OR of 1.24 [95% CI: 1.12-1.38]. Secondary analysis revealed an increased risk for NDD when fever occurred during the first trimester of gestation [OR 1.13-95% CI: 1.02-1.26]. LIMITATIONS: We excluded studies that considered infections with no evidence of fever. Another potential limitation may be the possible heterogeneity between study designs (cohorts and case-control). CONCLUSION: Additional evidence supported the association between fever during pregnancy and increased risk for NDD in offspring. Careful monitoring should be considered for children born from mothers with a febrile episode during pregnancy (specifically during the first trimester). En ligne : http://dx.doi.org/10.1186/s13229-021-00464-4 Permalink : https://www.cra-rhone-alpes.org/cid/opac_css/index.php?lvl=notice_display&id=459 Regulatory T lymphocytes/Th17 lymphocytes imbalance in autism spectrum disorders: evidence from a meta-analysis / P. ELLUL in Molecular Autism, 12 (2021)
![]()
[article]
Titre : Regulatory T lymphocytes/Th17 lymphocytes imbalance in autism spectrum disorders: evidence from a meta-analysis Type de document : Texte imprimé et/ou numérique Auteurs : P. ELLUL, Auteur ; M. ROSENZWAJG, Auteur ; H. PEYRE, Auteur ; G. FOURCADE, Auteur ; E. MARIOTTI-FERRANDIZ, Auteur ; V. TREBOSSEN, Auteur ; D. KLATZMANN, Auteur ; R. DELORME, Auteur Article en page(s) : 68 p. Langues : Anglais (eng) Mots-clés : Asd Immunology Peripheral blood Regulatory T lymphocyte Th17 lymphocytes Index. décimale : PER Périodiques Résumé : BACKGROUND: Immune system dysfunction has been proposed to play a critical role in the pathophysiology of autism spectrum disorders (ASD). Conflicting reports of lymphocyte subpopulation abnormalities have been described in numerous studies of patients with ASD. To better define lymphocytes abnormalities in ASD, we performed a meta-analysis of the lymphocyte profiles from subjects with ASD. METHODS: We used the PRISMA recommendations to query PubMed, Embase, PsychoINFO, BIOSIS, Science Direct, Cochrane CENTRAL, and Clinicaltrials.gov for terms related to clinical diagnosis of ASD and to lymphocytes' populations. We selected studies exploring lymphocyte subpopulations in children with ASD. The search protocol has been registered in the international Prospective Register of Systematic Reviews (CRD42019121473). RESULTS: We selected 13 studies gathering 388 ASD patients and 326 healthy controls. A significant decrease in the CD4+?lymphocyte was found in ASD patients compared to controls [-?1.51 (95% CI?-?2.99;?-?0.04) p?=?0.04] (I(2)?=?96% [95% CI 94.6, 97.7], p?0.01). No significant difference was found for the CD8+?T, B and natural killer lymphocytes. Considering the CD4+?subpopulation, there was a significant decrease in regulatory T lymphocytes (Tregs) in ASD patients (n?=?114) compared to controls (n?=?107) [-?3.09 (95% CI?-?4.41;?-?1.76) p?=?0.0001]; (I(2)?=?90.9%, [95% CI 76.2, 96.5], p?0.0001) associated with an increase oin the Th17 lymphocytes (ASD; n?=?147 controls; n?=?128) [2.23 (95% CI 0.79; 3.66) p?=?0,002] (I(2)?=?95.1% [95% CI 90.4, 97.5], p?0.0001). LIMITATIONS: Several factors inducing heterogeneity should be considered. First, differences in the staining method may be responsible for a part in the heterogeneity of results. Second, ASD population is also by itself heterogeneous, underlying the need of studying sub-groups that are more homogeneous. CONCLUSION: Our meta-analysis indicates defects in CD4+?lymphocytes, specifically decrease oin Tregs and increase in Th17 in ASD patients and supports the development of targeted immunotherapies in the field of ASD. En ligne : http://dx.doi.org/10.1186/s13229-021-00472-4 Permalink : https://www.cra-rhone-alpes.org/cid/opac_css/index.php?lvl=notice_display&id=459
in Molecular Autism > 12 (2021) . - 68 p.[article] Regulatory T lymphocytes/Th17 lymphocytes imbalance in autism spectrum disorders: evidence from a meta-analysis [Texte imprimé et/ou numérique] / P. ELLUL, Auteur ; M. ROSENZWAJG, Auteur ; H. PEYRE, Auteur ; G. FOURCADE, Auteur ; E. MARIOTTI-FERRANDIZ, Auteur ; V. TREBOSSEN, Auteur ; D. KLATZMANN, Auteur ; R. DELORME, Auteur . - 68 p.
Langues : Anglais (eng)
in Molecular Autism > 12 (2021) . - 68 p.
Mots-clés : Asd Immunology Peripheral blood Regulatory T lymphocyte Th17 lymphocytes Index. décimale : PER Périodiques Résumé : BACKGROUND: Immune system dysfunction has been proposed to play a critical role in the pathophysiology of autism spectrum disorders (ASD). Conflicting reports of lymphocyte subpopulation abnormalities have been described in numerous studies of patients with ASD. To better define lymphocytes abnormalities in ASD, we performed a meta-analysis of the lymphocyte profiles from subjects with ASD. METHODS: We used the PRISMA recommendations to query PubMed, Embase, PsychoINFO, BIOSIS, Science Direct, Cochrane CENTRAL, and Clinicaltrials.gov for terms related to clinical diagnosis of ASD and to lymphocytes' populations. We selected studies exploring lymphocyte subpopulations in children with ASD. The search protocol has been registered in the international Prospective Register of Systematic Reviews (CRD42019121473). RESULTS: We selected 13 studies gathering 388 ASD patients and 326 healthy controls. A significant decrease in the CD4+?lymphocyte was found in ASD patients compared to controls [-?1.51 (95% CI?-?2.99;?-?0.04) p?=?0.04] (I(2)?=?96% [95% CI 94.6, 97.7], p?0.01). No significant difference was found for the CD8+?T, B and natural killer lymphocytes. Considering the CD4+?subpopulation, there was a significant decrease in regulatory T lymphocytes (Tregs) in ASD patients (n?=?114) compared to controls (n?=?107) [-?3.09 (95% CI?-?4.41;?-?1.76) p?=?0.0001]; (I(2)?=?90.9%, [95% CI 76.2, 96.5], p?0.0001) associated with an increase oin the Th17 lymphocytes (ASD; n?=?147 controls; n?=?128) [2.23 (95% CI 0.79; 3.66) p?=?0,002] (I(2)?=?95.1% [95% CI 90.4, 97.5], p?0.0001). LIMITATIONS: Several factors inducing heterogeneity should be considered. First, differences in the staining method may be responsible for a part in the heterogeneity of results. Second, ASD population is also by itself heterogeneous, underlying the need of studying sub-groups that are more homogeneous. CONCLUSION: Our meta-analysis indicates defects in CD4+?lymphocytes, specifically decrease oin Tregs and increase in Th17 in ASD patients and supports the development of targeted immunotherapies in the field of ASD. En ligne : http://dx.doi.org/10.1186/s13229-021-00472-4 Permalink : https://www.cra-rhone-alpes.org/cid/opac_css/index.php?lvl=notice_display&id=459